Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1992-04-23
1993-09-07
Fay, Zohreh A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514912, A61K 31135
Patent
active
052429504
ABSTRACT:
A method of treating macular degeneration is disclosed which comprises administering to a patient suffering from the disease a therapeutically effective amount of L-deprenyl or a pharmaceutically acceptable acid addition salt thereof for a period of time sufficient to ameliorate the disease.
REFERENCES:
patent: 4861800 (1989-08-01), Buyske
patent: 4868218 (1989-09-01), Buyske
patent: 4925878 (1990-05-01), Bodo et al.
Age-Related Macular Degeneration, Lawrence A. Yannuzzi et al, pp. 1-64.
New York Academy of Medicine Opthamology Section Meeting, Dec. 7, 1987.
For My Patient-Macular Degeneration, Howard Schatz MD et al, pp. 1-51 The Retina Research Fund 1989.
The Current Status of Monoamine Oxidase and its Inhibitors, Jarrott et al The Medical Journal of Australia vol. 146, pp. 634-638, Jun. 15, 1987.
Etiology of Parkinson's Disease: Current Concepts, Roger C. Duvoisin Clinical Neuropharmacology, vol. 9, Suppl. 1 pp. S3-S21 (1986).
Changes in Local Cerebral Glucose Utilization Associated with Parkinson's Syndrome Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) in the Primate, L. J. Porrino et al Life Sciences, vol. 40, pp. 1657-1664 (1987).
Senile Macular Degeneration, Philip L. Penfold et al. Invest. Opthalmology and Visual Science, vol. 27, No. pp. 364-371 (1986).
Studies on the Effect of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) on Central Catecholamine Neurons in C57 BL/6 Mice. Comparison with Three Other Strains of Mice, Sundstrom et al, Brain Research, 405 (1982) pp. 26-38.
Dysfunction and Death of Neurons in Human Degenerative Neurological Diseases and in Animal Models, Donald L. Price et al CIBA Foundation Symposium 126 pp. 30-48 (1987).
Role of B-Type Monoamine Oxidase Inhibition in the Treatment of Parkinson's Disease, Joseph Knoll. Movement Disorders, pp. 53-81 (1986).
Neurology of the Viral System, pp. 75-97 (1967).
Correlative Anatomy of the Nervous System, Elizabeth Crosby et al pp. 434-463 (1962).
Fay Zohreh A.
Somerset Pharmaceuticals, Inc.
LandOfFree
Treatment of macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of macular degeneration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-488157